Literature DB >> 24309484

Transfer of antigen from human B cells to dendritic cells.

Bohdan P Harvey1, Maurice T Raycroft1, Timothy E Quan1, Benjamin J Rudenga1, Robert M Roman1, Joe Craft1, Mark J Mamula2.   

Abstract

The cooperation of B lymphocytes with other antigen presenting cells (APCs) is often necessary in the efficient processing and presentation of antigen. Herein, we describe a mechanism by which B cells physically interact with dendritic cells (DCs) resulting in the transfer of B cell receptor (BCR)-enriched antigen to these APCs. Antigen transfer involves direct contact between the two cells followed by the capture of B cell derived membrane and intracellular components. Strikingly, DCs acquire greater amounts of antigen by transfer from B cells than by endocytosis of free antigen. Blocking scavenger receptor A, a DC surface receptor involved in membrane acquisition, abrogates these events. We propose that antigen transfer from B cells to DCs results in a more focused immunologic response due to the selective editing of Ag by the BCR.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AF488; Alexa Fluor(®) 488; Antigen presentation/processing; B cells; B lymphoblastoid cell line; B-LCL; CTFR; CTO; CellTrace™ Far Red; CellTracker™ Orange; Dendritic cells; IC; MdDC; MoDC; SR-A; Scavenger receptor A; TW; aIg; anti-human IgG/M F(ab′)2; class A scavenger receptor; immune complex; monocyte derived DC; myeloid DC; transwell

Mesh:

Substances:

Year:  2013        PMID: 24309484      PMCID: PMC4234097          DOI: 10.1016/j.molimm.2013.10.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  49 in total

1.  Cross-presentation by intercellular peptide transfer through gap junctions.

Authors:  Joost Neijssen; Carla Herberts; Jan Wouter Drijfhout; Eric Reits; Lennert Janssen; Jacques Neefjes
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

2.  Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response.

Authors:  M Wykes; A Pombo; C Jenkins; G G MacPherson
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

3.  A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.

Authors:  O Chan; M J Shlomchik
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  Scavenger receptors mediate adhesion of activated B lymphocytes.

Authors:  T Yokota; B Ehlin-Henriksson; G K Hansson
Journal:  Exp Cell Res       Date:  1998-02-25       Impact factor: 3.905

Review 5.  Dendritic cells: unique leukocyte populations which control the primary immune response.

Authors:  D N Hart
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

Review 6.  Vascular biology of CD36: roles of this new adhesion molecule family in different disease states.

Authors:  L Daviet; J L McGregor
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

7.  B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity.

Authors:  R Roth; R J Gee; M J Mamula
Journal:  Ann N Y Acad Sci       Date:  1997-04-05       Impact factor: 5.691

8.  Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.

Authors:  Hans Christian Probst; Maries van den Broek
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

9.  The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid.

Authors:  D W Dunne; D Resnick; J Greenberg; M Krieger; K A Joiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.

Authors:  K Inaba; S Turley; F Yamaide; T Iyoda; K Mahnke; M Inaba; M Pack; M Subklewe; B Sauter; D Sheff; M Albert; N Bhardwaj; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  7 in total

1.  Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.

Authors:  Jennifer L Booth; Todd M Umstead; Sanmei Hu; Kevin F Dybvig; Timothy K Cooper; Ronald P Wilson; Zissis C Chroneos
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

2.  Oxidation by neutrophils-derived HOCl increases immunogenicity of proteins by converting them into ligands of several endocytic receptors involved in antigen uptake by dendritic cells and macrophages.

Authors:  Rafał Biedroń; Maciej K Konopiński; Janusz Marcinkiewicz; Szczepan Józefowski
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

3.  Trogocytosis with monocytes associated with increased α2,3 sialic acid expression on B cells during H5N1 influenza virus infection.

Authors:  Supasek Kongsomros; Maytawan Thanunchai; Suwimon Manopwisedjaroen; Prasit Na-Ek; Sheng-Fan Wang; Tana Taechalertpaisarn; Arunee Thitithanyanont
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

4.  B cells and cancer: To B or not to B?

Authors:  Wolf Herman Fridman; Florent Petitprez; Maxime Meylan; Tom Wei-Wu Chen; Cheng-Ming Sun; Lubka T Roumenina; Catherine Sautès-Fridman
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

Review 5.  Antigen transfer and its effect on vaccine-induced immune amplification and tolerance.

Authors:  Yingying Shi; Yichao Lu; Jian You
Journal:  Theranostics       Date:  2022-08-01       Impact factor: 11.600

Review 6.  From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 7.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.